iatroX logo
brainstormaskiatroXuk q-bankus q-bankknowledge centreblog
Knowledge Centre / Self-Harm

Self-Harm

Assessment and management of self-harm.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Mental HealthEmergency Medicine

Clinical Guidelines

CKS: Self-harm
National
NICE guideline [NG225]
National
NICE guideline [NG225]: Self-harm: assessment, management and preventing recurrence
National
Self-harm in over 8s: long-term management
National
Deliberate self-harm clinical practice guideline (RANZCP)
Local
NICE clinical guideline [CG133]: Self-harm: longer-term management
Local
NICE clinical guideline [CG16]: Self-harm in over 8s: short-term management and prevention of recurrence
Local
NICE guideline [NG225]: Self-harm: assessment, management and preventing recurrence
Local
NICE guideline [NG225]: Self-harm: assessment, management and preventing recurrence
Local

Recent iatroX Q&As

  • What are the key components of a comprehensive assessment for a patient who has self-harmed?Updated: 8/16/2025
  • How should I approach the management of self-harm in adolescents compared to adults?Updated: 8/16/2025
  • What criteria should I use to determine whether to refer a patient who has self-harmed to mental health services?Updated: 8/16/2025
  • What are the recommended follow-up strategies for patients who have presented with self-harm in primary care?Updated: 8/16/2025
  • How can I effectively engage with patients who are reluctant to discuss their self-harm behaviors?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsightsfaqabout
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play